ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,825Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 617

$522K Total Retail Price of All Prescriptions

Rank: 89 out of 617

478 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,855 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 954 843 1 2
OMEPRAZOLE 662 553 2 3
LISINOPRIL 648 601 3 5
WARFARIN SODIUM 577 564 4 7
LEVOTHYROXINE SODIUM 561 544 5 1
AMLODIPINE BESYLATE 449 405 6 6
CITALOPRAM HBR 349 304 7 18
POTASSIUM CHLORIDE 335 328 8 10
METFORMIN HCL 321 271 9 9
FUROSEMIDE 318 292 10 4
HYDROCODONE-ACETAMINOPHEN 235 185 S3 11 8
HYDROCHLOROTHIAZIDE 228 197 12 13
CARVEDILOL 227 224 13 19
ALLOPURINOL 214 184 14 27
ATENOLOL 204 196 15 17
METOPROLOL SUCCINATE 186 173 16 12
TRAMADOL HCL 181 136 17 15
METOPROLOL TARTRATE 175 168 18 11
ENALAPRIL MALEATE 172 169 19 34
GLIMEPIRIDE 160 137 20 33
ALENDRONATE SODIUM 159 154 21 25
POLYETHYLENE GLYCOL 3350 159 159 21 32
ATORVASTATIN CALCIUM 150 149 23 14
CLONIDINE HCL 144 125 24 55
SERTRALINE HCL 139 102 25 20
LANTUS 136 128 26 39
BENAZEPRIL HCL 133 100 27 44
ZOLPIDEM TARTRATE 124 94 28 23
ADVAIR DISKUS 123 108 29 38
GABAPENTIN 121 97 30 16
SPIRONOLACTONE 115 103 31 42
DIGOXIN 114 111 32 48
LOSARTAN POTASSIUM 114 111 32 22
TAMSULOSIN HCL 113 102 34 26
DILTIAZEM ER 108 105 35 81
DONEPEZIL HCL 105 104 36 30
RANITIDINE HCL 102 69 37 40
NAMENDA 99 99 38 35
TRAZODONE HCL 93 74 39 51
MIRTAZAPINE 92 92 40 50
FLUTICASONE PROPIONATE 89 72 41 36
PRAVASTATIN SODIUM 88 79 42 21
BUMETANIDE 87 87 43 124
PREDNISONE 82 44 44 31
AMLODIPINE BESYLATE-BENAZEPRIL 81 81 45 80
TRICOR 80 62 46 83
TRIAMTERENE-HCTZ 78 73 47 47
DIOVAN 78 67 47 41
PROAIR HFA 69 59 49 75
PAROXETINE HCL 68 55 50 62
SPIRIVA 67 39 51 61
CLOPIDOGREL 64 50 52 53
NAPROXEN 63 30 53 101
FLUOXETINE HCL 63 48 53 73
CRESTOR 61 51 55 28
RISPERIDONE 60 39 56 71
DOXAZOSIN MESYLATE 59 55 57 79
SYNTHROID 59 59 57 59
ROPINIROLE HCL 55 51 59 66
AMIODARONE HCL 53 53 60 129
NABUMETONE 52 52 61 120
FENTANYL 52 34 S2 61 45
CYMBALTA 52 42 61 49
VESICARE 51 32 64 95
BYSTOLIC 51 33 64 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 50 66 29
PHENYTOIN SODIUM EXTENDED 50 48 66 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.